🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Our Mayo Clinic Membranous Nephropathy Consensus Report is finally out. A year in the making. The manuscript brings together the recent advances in MN. I am very thankful to all my collaborators. Mayo Clinic Nephrology Mayo Clinic Mayo Clinic Pathology sciencedirect.com/science/articl…

The media doesn't seem to understand that long ER wait times are caused by Alternative Level of Care patients occupying 20% of acute care hospital beds because of inadequate long term care services (home care, nursing home care and assisted living) in the community.

Lukasz Kiljanek MD Juan Carlos Q Velez 𝐑𝐚𝐥𝐩𝐡 𝐌𝐨𝐡𝐭𝐲 𝐌𝐃 𝐌𝐏𝐇 Florian Buchkremer Amy Yau @NephroMD Frederik H. Verbrugge So many cases are mixtures of low average solute intake, high average electrolyte free water intake, and a mild dilution defect (SIADH) . Try teaching that in one sitting.

🔔 Today at #KidneyWk, Dr Bryce Barr will be presenting data from the Manitoba Glomerular Diseases Registry - a comprehensive database with linked biopsy + admin data. His poster is focused on the characteristics & outcomes of the sub-cohort with IgA nephropathy. Poster # PO620

Absolutely incredible benefits in reducing CKD progression with these four therapies. Now we just need Pharmacare on board!

Bryce Barr tuning in late from Winnipeg, Canada. Mainly lurking, no COI #NephTrials

2x key EMPA-KIDNEY papers exploring effects by uACR, eGFR, type of diabetes & primary kidney disease in The Lancet Diabetes & Endocrinology. Core Dec 2023 open access reading b4 you start your Xmas novel! (some of the most informative data on #SGLT2i in non-albuminuric #CKD…)🌲🎁 from Oxford Population Health (OxPop)

Improved uptake of SGLT2i in people with CKD has the potential to substantially reduce the incidence of kidney failure in Australia Implementation now critical to realising these population level benefits Our new paper #openaccess in The Lancet Reg Health-West Pacific thelancet.com/journals/lanwp…

Eric Weinhandl This narrative needs to die. I get the article is on how companies are being marked the drugs etc, but we don't ask people to stop PCSK9i ($$$) or anti hypertensives or insulin, so why the obsession with this?

What an awesome week for Canadian Aaron Cockerill on the Euro Tour. T4 in Dubai. The dude has been grinding over there for years. Hanging on to his card with clutch finishes, now off to a great start in 2024. Awesome to see.

Whenever I see a guideline insisting we're all Vitamin D deficient, I get a sinking feeling I'm reading the legacy of bad science. Meta-scientists often complain how Vitamin D research is, as a field, so methodologically shabby as to be meaningless. How bad? Well let's dig in...

A full house for Drs. Stephanie Garner and Bryce Barr presenting their workshop on a practical and case-based approach to vasculitis at #ASM24! The CRA would like to hear from you! What’s a highlight of the ASM so far?

Happy to see this article published. Sean Barbour and I discuss the latest in IgAN therapy. It’s an exciting time in a disease where the bar is high to prevent kidney failure.

🎉 Congratulations to CDIC Collaborator Dr. Bryce Barr on receiving an Operating Grant from the Manitoba Medical Service Foundation! Read more about his research project, as well as the projects from other rising new investigators in the province: mmsf.ca/current-grant-…

Great read on IgA Nephropathy - very thoughtful approach on how to use currently available therapies with lots of food for thought for future trials

If you treat membranous nephropathy, be sure to complete this survey! #nephtwitter

If you have a few moments to listen to this interview as a parent with your child. Possible one of the best post race interviews I have ever watched #PlayOn

#askrenal David Collister Navdeep Tangri Swapnil Hiremath @hswapnil.medsky.social Brendon Neuen Any data on safety of GLP-1 at FLOW dosing in individuals with normal or low-normal BMI who have DKD? Looking specifically for functional status, sarcopenia, weight loss

The bar is high to prevent kidney failure in IgAN, and the evidence base is rapidly evolving. Excited to discuss a contemporary approach to treatment, using the treatments available to us in Canada!

Simple concept of GN. It’s all about location! 1. Subendothelial deposits/injury by Ig, immune-complexes, complement, other mechanism leads to influx of leukocytes= inflammation=GN 2. Subepithelial deposits/injury= protected by GBM & endothelial cells=no inflammation=No GN. 1/3